A 58-year-old man, a non-smoking clerical worker, presented in May 1978 with an eight-month history of lethargy, weight loss, and a cough productive of mucoid sputum, and increasing shortness of breath for two months. Raynaud's phenomenon had been present for 36 years. On examination he was ill but apyrexial, dyspnoeic on the slightest exertion, with telangiectasia on his face, crackles in the chest, and splenomegaly. His chest radiograph is shown in figure 1. Sputum and blood cultures were sterile. Serological tests for common respiratory viruses, Mycoplasma pneumoniae, Coxiella burnetti, the psittacosis agent, and Legionella pneumophila gave negative results. His haemoglobin concentration was 15S2 g/dl, white blood count 13-7 x 109/l (normal differential), ESR 49 mm in one hour, serum IgM 1192 IU/ml (normal 58-197) Over the next year the dose of prednisolone was gradually reduced to 15 mg on alternate days and treatment continued at this dose until August 1980. Sclerodactyly was noted at this time and he complained of acid regurgitation. A barium swallow showed a dilated oesophagus and diminished peristalsis (a previous one had shown nothing abnormal). The chest radiograph had not changed for many months (that is, during maintenance steroid treatment) and showed only residual shadowing in the lingula. Radiographs of the hands showed calcinosis. Liver tests continued to show evidence of cholestasis, and endoscopic retrograde cholangiopancreatography performed at this time showed a normal biliary system but an abnormal pancreas, with stricturing and irregularity of the main pancreatic duct in the tail of the pancreas.
The dose of prednisolone was gradually reduced over the next six months, and when he had been having 5 mg on alternate days for three months he developed increasing shortness of breath and lethargy. There was fresh confluent shadowing in the right upper zone. The findings at bronchoscopy were normal. This shadowing rapidly resolved with an increase in the dose of prednisolone.
Discussion
Pulmonary disease in systemic sclerosis is usually manifest radiologically as lower-zone shadowing, but confluent 
